Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy

European Radiology

Volumn 18, Issue 2, 2008, Pages 343-350

  Kettritz, Ute ^a  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Ductal carcinoma in situ; Mammography; Vacuum assisted breast biopsy

Indexed keywords

ARTICLE; BIOPSY TECHNIQUE; BREAST BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CARCINOMA IN SITU; HEALTH CARE COST; HUMAN; INTRADUCTAL CARCINOMA; NEEDLE BIOPSY; OUTCOME ASSESSMENT; PERCUTANEOUS BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BIOPSY; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; SENSITIVITY AND SPECIFICITY; VACUUM;

EID: 39049119772     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0753-4     Document Type: Article

References (69)

1. Winchester DP, Strom EA (1998) Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 48:108-128
2. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160:953-958
3. Feig SA (2000) Ductal carcinoma in situ. Implications for screening mammography. Radiol Clin North Am 38:653-668, vii
4. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle-aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814-819
5. Pollei SR, Mettler FA Jr, Bartow SA, Moradian G, Moskowitz M (1987) Occult breast cancer: Prevalence and radiographic detectability. Radiology 163:459-462
6. Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796-807
7. Kopans DB, Rafferty E, Georgian-Smith D et al (2003) A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 97:2951-2959
8. Boecker W, Buerger H (2003) Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: A new progenitor (adult stem) cell concept. Cell Prolif 36(Suppl 1):73-84
9. Boecker W (2006) Preneoplasia of the breast. Elsevier Saunders, Munich
10. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM (2004) Ductal carcinoma in situ of the breast. N Engl J Med 350:1430-1441
11. Gallager HS, Martin JE, Moore DL, Paulus DD (1979) The detection and diagnosis of early occult and minimal breast cancer. Curr Probl Cancer 3:1-32
12. Betsill WL, Rosen PP, Lieberman PH et al (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239:1863-1867
13. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197-1200
14. Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154-1157
15. Bijker N, Meijnen P, Peterse JL et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387
16. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231-273
17. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335:519-522
18. Lagios MD (1990) Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70:853-871
19. Ohtake T, Kimijima I, Fukushima T et al (2001) Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: Implications of ductal anastomoses for breast-conserving surgery. Cancer 91:2263-2272
20. Faverly DR, Burgers L, Bult P, Holland R (1994) Three dimensional imaging of mammary ductal carcinoma in situ: Clinical implications. Semin Diagn Pathol 11:193-198
21. Tavassoli FA (1999) Pathology of the breast. McGraw-Hill, New York
22. Holland R, Peterse JL, Millis RR et al (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11:167-180
23. Sloane JP, Amendoeira I, Apostolikas N et al (1998) Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European commission working group on breast screening pathology. Hum Pathol 29:1056-1062
24. Lagios MD, Margolin FR, Westdahl PR, Rose MR (1989) Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624
25. Solin LJ, Yeh IT, Kurtz J et al (1993) Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 71:2532-2542
26. Silverstein MJ, Lagios MD, Craig PH et al (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267-2274
27. Evans AJ, Pinder S, Ellis IO et al (1994) Screening-detected and symptomatic ductal carcinoma in situ: Mammographic features with pathologic correlation. Radiology 191:237-240
28. Stomper PC, Connolly JL, Meyer JE, Harris JR (1989) Clinically occult ductal carcinoma in situ detected with mammography: Analysis of 100 cases with radiologic-pathologic correlation. Radiology 172:235-241
29. Holland R, Hendriks JH (1994) Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation. Semin Diagn Pathol 11:181-192
30. Morakkabati-Spitz N, Leutner C, Schild H, Traeber F, Kuhl C (2005) Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 15:2010-2017
31. Oshida K, Nagashima T, Ueda T et al (2005) Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol 15:1353-1360
32. Leinsinger G, Schlossbauer T, Scherr M, Lange O, Reiser M, Wismuller A (2006) Cluster analysis of signal-intensity time course in dynamic breast MRI: Does unsupervised vector quantization help to evaluate small mammographic lesions? Eur Radiol 16:1138-1146
33. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T (2006) The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 192:172-178
34. Kettritz U, Morack G, Decker T (2005) Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: Radiological and pathological correlations. Eur J Radiol 55:270-276
35. American College of Radiology (2003) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas), 4th edn. American College of Radiology, Reston
36. Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD (1998) The breast imaging reporting and data system: Positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol 171:35-40
37. Fondrinier E, Lorimier G, Guerin-Boblet V, Bertrand AF, Mayras C, Dauver N (2002) Breast microcalcifications: Multivariate analysis of radiologic and clinical factors for carcinoma. World J Surg 26:290-296.
38. Evans A, Pinder S, Wilson R et al (1994) Ductal carcinoma in situ of the breast: Correlation between mammographic and pathologic findings. AJR Am J Roentgenol 162:1307-1311
39. Jackman RJ, Marzoni FA Jr (1997) Needle-localized breast biopsy: Why do we fail? Radiology 204:677-684
40. Abrahamson PE, Dunlap LA, Amamoo MA, Schell MJ, Braeuning MP, Pisano ED (2003) Factors predicting successful needle-localized breast biopsy. Acad Radiol 10:601-606
41. Rissanen TJ, Makarainen HP, Mattila SI et al (1993) Wire localized biopsy of breast lesions: A review of 425 cases found in screening or clinical mammography. Clin Radiol 47:14-22
42. Liberman L, LaTrenta LR, Dershaw DD et al (1997) Impact of core biopsy on the surgical management of impalpable breast cancer. AJR Am J Roentgenol 168:495-499
43. Gundry KR, Berg WA (1998) Treatment issues and core needle breast biopsy: Clinical context. AJR Am J Roentgenol 171:41-49
44. Verkooijen HM, Borel Rinkes IH, Peeters PH et al (2001) Impact of stereotactic large-core needle biopsy on diagnosis and surgical treatment of nonpalpable breast cancer. Eur J Surg Oncol 27:244-249
45. Pisano ED, Fajardo LL, Tsimikas J et al (1998) Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The radiologic diagnostic oncology group 5 study. The RDOG5 investigators. Cancer 82:679-688
46. Parker SH, Burbank F, Jackman RJ et al (1994) Percutaneous large-core breast biopsy: A multi-institutional study. Radiology 193:359-364
47. Verkooijen HM (2002) Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 99:853-859
48. Schulz-Wendtland R, Kramer S, Lang N, Bautz W (1998) Ultrasonic guided microbiopsy in mammary diagnosis: Indications, technique and results. Anticancer Res 18:2145-2146
49. Brenner RJ, Fajardo L, Fisher PR et al (1996) Percutaneous core biopsy of the breast: Effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol 341-346
50. Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH (1999) Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol 172:683-687
51. Jackman RJ, Rodriguez-Soto J (2006) Breast microcalcifications: retrieval failure at prone stereotactic core and vacuum breast biopsy - frequency, causes, and outcome. Radiology 239:61-70
52. Burbank F, Parker SH, Fogarty TJ (1996) Stereotactic breast biopsy: improved tissue harvesting with the Mammotome. Am Surg 738-744.
53. Parker SH, Klaus AJ (1997) Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics 17:1233-1252
54. Meyer JE, Smith DN, DiPiro PJ et al (1997) Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device. Radiology 204:575-576
55. Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP (1998) Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 208:251-260
56. Stomper PC, Margolin FR (1994) Ductal carcinoma in situ: The mammographer's perspective. AJR Am J Roentgenol 162:585-591
57. Kettritz U, Rotter K, Schreer I et al (2004) Stereotactic vacuum-assisted breast biopsy in 2874 patients. Cancer 100:245-251
58. Heywang-Kobrunner SH, Schreer I, Decker T, Böcker W (2003) Interdisciplinary consensus on the use and technique of vacuum assisted stereotactic breast biopsy. Eur J Radiol 47:232-236
59. Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461
60. Silverstein MJ, Barth A, Poller DN et al (1995) Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31A:1425-1427
61. Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G et al (2001) Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment-the experience of one institute. Am J Clin Oncol 24:531-536
62. Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol 16:441-452
63. Julien JP, Bijker N, Fentiman IS et al (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533
64. Mokbel K, Cutuli B (2006) Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol 7:756-765
65. Moran CJ, Kell MR, Flanagan FL, Kennedy M, Gorey TF, Kerin MJ (2007) Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Am J Surg 194:172-175
66. Darling ML, Smith DN, Lester SC et al (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision. AJR Am J Roentgenol 175:1341-1346
67. Won B, Reynolds HE, Lazaridis CL, Jackson VP (1999) Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: Persistent underestimation of disease. AJR Am J Roentgenol 173:227-229
68. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP (1995) Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: An indication for surgical biopsy. AJR Am J Roentgenol 164:1111-1113
69. Jackman RJ, Burbank F, Parker SH et al (2001) Stereotactic breast biopsy of nonpalpable lesions: Determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497-502